ArticlePloS one2015

Potential Antileukemia Effect and Structural Analyses of SRPK Inhibition by N-(2-(Piperidin-1-yl)-5-(Trifluoromethyl)Phenyl)Isonicotinamide (SRPIN340).

Raoni Pais Siqueira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.